The Effect of Arthrocentesis Treatment for Maximum Mouth Opening and Pain in Temporomandibular Joint Diseases and the Effect of Splint, Drug, and Physical Therapy on This Treatment
Abstract
:1. Introduction
2. Materials and Methods
2.1. Splint Treatment
2.2. Muscle Relaxant and Anti-Inflammatory
2.3. Physical Therapy
2.4. Statistical Evaluation
3. Results
4. Discussion
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Scrivani, S.J.; Keith, D.A.; Kaban, L.B. Temporomandibular disorders. N. Engl. J. Med. 2008, 359, 2693–2705. [Google Scholar] [CrossRef] [PubMed]
- Ahmad, M.; Hollender, L.; Anderson, Q.; Kartha, K.; Ohrbach, R.; Truelove, E.L.; John, M.T.; Schiffman, E.L. Research diagnostic criteria for temporomandibular disorders (RDC/TMD): Development of image analysis criteria and examiner reliability for image analysis. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod. 2009, 107, 844–860. [Google Scholar] [CrossRef]
- National Institute of Dental and Craniofacial Research. Data & Statistics of Facial Pain. Available online: https://www.nidcr.nih.gov/research/data-statistics/facial-pain (accessed on 1 April 2020).
- Demir, M.G. Comparison of symptoms, signs, gender, and magnetic resonance images of temporomandibular joint disorder patients. Cranio 2022, 28, 1–5. [Google Scholar] [CrossRef]
- Dahlström, L.; Carlsson, G.E. Temporomandibular disorders and oral health-related quality of life. A systematic review. Acta Odontol. Scand. 2010, 68, 80–85. [Google Scholar] [CrossRef] [PubMed]
- Maisa Soares, G.; Rizzatti-Barbosa, C.M. Chronicity factors of temporomandibular disorders: A critical review of the literature. Braz. Oral. Res. 2015, 29, 1–6. [Google Scholar] [CrossRef]
- Schiffman, E.; Ohrbach, R.; Truelove, E.; Look, J.; Anderson, G.; Goulet, J.P.; List, T.; Svensson, P.; Gonzalez, Y.; Lobbezoo, F.; et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for clinical and research applications: Recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group. J. Oral Facial Pain Headache 2014, 28, 6–27. [Google Scholar] [CrossRef]
- Hye-Sung, L.; Hyun-Su, B.; Dong-Suk, S.; Hee-Chul, K. Effect of simultaneous therapy of arthrocentesis and occlusal splints on temporomandibular disorders: Anterior disc displacement without reduction. J. Korean Assoc. Oral. Maxillofac. Surg. 2013, 39, 14–20. [Google Scholar]
- Tvrdy, P.; Heinz, P.; Zapletalova, J.; Pink, R.; Michl, P. Effect of combination therapy of arthrocentesis and occlusal splint on nonreducing temporomandibular joint disk displacement. Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc Czech Repub. 2015, 159, 677–680. [Google Scholar] [CrossRef]
- Nitzan, D.W.; Dolwick, M.F.; Martinez, G.A. Temporomandibular joint arthrocentesis: A simplified treatment for severe, limited mouth opening. J. Oral. Maxillofac. Surg. 1991, 49, 1163–1167. [Google Scholar] [CrossRef]
- Altaweel, A.A.; Ismail, H.A.; Fayad, M.I. Effect of simultaneous application of arthrocentesis and occlusal splint versus splint in management of non-reducing TMJ disc displacement. J. Dent. Sci. 2021, 16, 732–737. [Google Scholar] [CrossRef]
- Casares, G.; Thomas, A.; Carmona, J.; Acero, J.; Vila, C.N. Influence of oral stabilization appliances in intraarticular pressure of the temporomandibular joint. Cranio 2014, 32, 219–223. [Google Scholar] [CrossRef] [PubMed]
- Okeson, J.P. Joint intracapsular disorders: Diagnostic and non surgical management considerations. Dent. Clin. N. Am. 2007, 51, 85–103. [Google Scholar] [CrossRef] [PubMed]
- Holmlund, A.; Hellsing, G. Arthroscopy of the temporomandibular joint. An autopsy study. Int. J. Oral. Surg. 1985, 14, 169–175. [Google Scholar] [CrossRef] [PubMed]
- McCain, J.P. Arthroscopy of the human temporomandibular joint. J. Oral. Maxillofac. Surg. 1988, 46, 648–655. [Google Scholar] [CrossRef]
- Damlar, I.; Esen, E.; Tatli, U. Effects of glucosamine-chondroitin combination on synovial fluid il-1beta, il-6, tnf-alpha and pge2 levels in internal derangements of temporomandibular joint. Med. Oral. Patol. Oral. Cir. Bucal. 2015, 20, 278–283. [Google Scholar] [CrossRef] [PubMed]
- Lundh, H.; Westesson, P.L.; Eriksson, L.; Brooks, S.L. Temporomandibular joint disk displacement without reduction. Treatment with flat oc- clusal splint versus no treatment. Oral. Surg. Oral. Med. Oral. Pathol. 1992, 73, 655–658. [Google Scholar] [CrossRef]
- Monje-Gil, F.; Nitzan, D.; González-Garcia, R. Temporomandibular joint arthrocentesis. Review of the literature. Med. Oral. Patol. Oral. Cir. Bucal 2012, 17, 575–581. [Google Scholar] [CrossRef]
- Vos, L.M.; Slater, J.J.R.H.; Stegenga, B. Arthrocentesis as initial treatment for temporomandibular joint arthropathy: A randomized controlled trial. J. Cranio-Maxillofac. Surg. 2014, 42, e134–e139. [Google Scholar] [CrossRef]
- Demir, M.G. Investigation of maximum mouth opening in terms of age, weight, height and body mass index in Turkish adult population. Cranio 2023, 21, 1–6. [Google Scholar] [CrossRef]
- Tatli, U.; Benlidayi, M.E.; Ekren, O.; Salimov, F. Comparison of the effectiveness of three different treatment methods for temporomandibular joint disc displacement without reduction. Int. J. Oral. Maxillofac. Surg. 2017, 46, 603–609. [Google Scholar] [CrossRef]
- Alpaslan, C.; Dolwick, M.F.; Heft, M.W. Five-year retrospective evaluation of temporo-mandibular joint arthrocentesis. Int. J. Oral. Maxillofac. Surg. 2003, 32, 263–267. [Google Scholar] [CrossRef] [PubMed]
- Diraçoğlu, D.; Saral, I.B.; Keklik, B.; Kurt, H.; Emekli, U.; Ozçakar, L.; Karan, A.; Aksoy, C. Arthrocentesis versus nonsurgical methods in the treatment of temporomandibular disc displacement without reduction. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod. 2009, 108, 3–8. [Google Scholar] [CrossRef] [PubMed]
- De Riu, G.; Stimolo, M.; Meloni, S.M.; Soma, D.; Pisano, M.; Sembronio, S.; Tullio, A. Arthrocentesis and temporomandibular joint disorders: Clinical and radiological results of a prospective study. Int. J. Dent. 2013, 2013, 790648. [Google Scholar] [CrossRef]
- Kim, C.W.; Lee, S.J.; Kim, E.H.; Lee, D.K.; Kang, M.H.; Song, I.S.; Jun, S.H. Effect of arthrocentesis on the clinical outcome of various treatment methods for temporomandibular joint disorders. Maxillofac. Plast. Reconstr. Surg. 2019, 41, 44. [Google Scholar] [CrossRef]
- Cleland, J.; Palmer, J. Effectiveness of manual physical therapy, therapeutic exercise, and patient education on bilateral disc displacement without reduction- of the temporomandibular joint: A single-case design. J. Orthop. Sports Phys. Ther. 2004, 34, 535–548. [Google Scholar] [CrossRef] [PubMed]
- Murakami, K.; Hosaka, H.; Moriya, Y.; Segami, N.; Iizuka, T. Short-term treatment outcome study for the management of temporomandibular joint closed lock. A comparison of arthrocentesis to nonsurgical therapy and arthroscopic lysis and lavage. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod. 1995, 80, 253–257. [Google Scholar] [CrossRef] [PubMed]
- Nicolakis, P.; Erdogmus, B.; Kopf, A.; Djaber-Ansari, A.; Piehslinger, E.; Fialka-Moser, V. Exercise therapy for craniomandibular disorders. Arch. Phys. Med. Rehabil. 2000, 81, 1137–1142. [Google Scholar] [CrossRef]
Gender (Participant (n)) | Male (16) | Female (63) | p Value |
---|---|---|---|
Age (mean (SD)) | 35.4 (4.9) | 36.7 (6.1) | 0.57 |
MMO T0 (mm) (mean (SD)) | 35.7 (4.2) | 35.4 (5.2) | 0.71 |
MMO T1 (mm) (mean (SD)) | 42.1 (4.4) | 41.3 (4.3) | 0.67 |
MMO T2 (mm) (mean (SD)) | 42.0 (4.8) | 41.6 (5.1) | 0.35 |
T0 | T1 | T0–T1 (p Value) | T2 | T0–T2 (p Value) | |
---|---|---|---|---|---|
MMO (mean) (mm) | 36.1 | 41.4 | 5.3 (0.01) | 41.3 | 5.2 (0.002) |
VAS (mean) | 6.2 | 2.3 | −3.9 (0.02) | 2.1 | −4.1 (0.03) |
VAS Score | ||||||
---|---|---|---|---|---|---|
Number | T0 (Mean (SD)) | T1 (Mean (SD)) | p Value * | Difference of VAS (Mean (SD)) | p Value † | |
Appliance treatment | ||||||
No splint | 34 | 4.41 (1.68) | 1.87 (1.85) | <0.001 | −2.54 (1.67) | 0.238 a |
Splint tx | 45 | 5.11 (1.98) | 1.76 (1.65) | <0.001 | −3.35 (1.69) | |
Dx | ||||||
Group 1 | 22 | 4.66 (1.65) | 1.81 (1.54) | <0.001 | −2.85 (1.76) | 0.764 b |
Group 2 | 45 | 4.55 (1.79) | 1.76 (1.63) | <0.001 | −2.79 (1.64) | |
Group 3 | 12 | 4.52 (1.98) | 1.72 (1.46) | <0.001 | −2.8 (1.89) | |
Muscle relaxant and anti-inflamatuar drug | ||||||
No | 15 | 4.92 (2.65) | 2.11 (1.76) | <0.001 | −2.81 (1.55) | 0.368 a |
Yes | 64 | 4.98 (2.76) | 2.01 (1.65) | <0.001 | −2.97 (1.75) | |
Physical therapy | ||||||
No | 18 | 4.61 (2.41) | 2.31 (1.81) | <0.001 | −2.30 (1.44) | 0.266 a |
Yes | 61 | 4.88 (2.66) | 2.01 (1.61) | <0.001 | −2.87 (1.69) | |
Locking time | ||||||
Less than 6 months | 35 | 4.21 (1.67) | 1.73 (1.45) | <0.001 | −2.48 (1.98) | 0.759 a |
6 or more than 6 months | 41 | 4.12 (1.87) | 1.71 (1.56) | <0.001 | −2.41 (1.87) |
VAS Score | ||||||
---|---|---|---|---|---|---|
Number | T1 (Mean (SD)) | T2 (Mean (SD)) | p Value * | Difference of VAS (Mean (SD)) | p Value † | |
Appliance treatment | ||||||
No splint | 34 | 4.41 (1.68) | 1.90 (1.81) | <0.001 | −2.54 (1.67) | 0.231 a |
Splint tx | 45 | 5.11 (1.98) | 1.87 (1.75) | <0.001 | −3.35 (1.69) | |
Dx | ||||||
Group 1 | 22 | 4.66 (1.65) | 1.93 (1.74) | <0.001 | −2.85 (1.76) | 0.649 b |
Group 2 | 45 | 4.55 (1.79) | 1.86 (1.83) | <0.001 | −2.79 (1.64) | |
Group 3 | 12 | 4.52 (1.98) | 1.82 (1.66) | <0.001 | −2.8 (1.89) | |
Muscle relaxant and anti-inflamatuar drug | ||||||
No | 15 | 4.92 (2.65) | 2.31 (1.71) | <0.001 | −2.81 (1.55) | 0.887 a |
Yes | 64 | 4.98 (2.76) | 2.11 (1.61) | <0.001 | −2.97 (1.75) | |
Physical therapy | ||||||
No | 18 | 4.61 (2.41) | 2.31 (1.81) | <0.001 | −2.30 (1.44) | 0.561 a |
Yes | 61 | 4.88 (2.66) | 2.01 (1.61) | <0.001 | −2.87 (1.69) | |
Locking time | ||||||
Less than 6 months | 35 | 4.21 (1.67) | 1.79 (1.25) | <0.001 | −2.48 (1.98) | 0.894 a |
6 or more than 6 months | 44 | 4.12 (1.87) | 1.78 (1.46) | <0.001 | −2.41 (1.87) |
MMO | ||||||
---|---|---|---|---|---|---|
Number | T0 (Mean (SD)) | T1 (Mean (SD)) | p Value * | Difference of MMO (Mean (SD)) | p Value † | |
Appliance treatment | ||||||
No splint | 34 | 36.1 (5.8) | 41.8 (6.8) | <0.001 | −5.7 (3.7) | 0.339 a |
Splint tx | 45 | 36.9 (7.2) | 42.1 (5.9) | <0.001 | −5.2 (4.9) | |
Dx | ||||||
Group 1 | 22 | 34.2 (5.5) | 42.5 (6.4) | <0.001 | −8.3 (4.6) | 0.603 b |
Group 2 | 45 | 37.1 (4.7) | 42.9 (5.1) | <0.001 | −5.8 (4.7) | |
Group 3 | 12 | 37.2 (5.2) | 41.7 (6.1) | <0.001 | −4.5 (4.7) | |
Muscle relaxant and anti-inflamatuar drug | ||||||
No | 15 | 36.3 (5.1) | 41.9 (4.5) | <0.001 | −5.6 (4.3) | 0.692 a |
Yes | 64 | 37.8 (5.1) | 42.1 (4.9) | <0.001 | −4.3 (3.7) | |
Physical therapy | ||||||
No | 18 | 34.7 (5.5) | 42.8 (5.1) | <0.001 | −8.1 (4.6) | 0.467 a |
Yes | 61 | 37.0 (4.6) | 42.1 (5.2) | <0.001 | −5.1 (4.1) | |
Locking time | ||||||
Less than 6 months | 35 | 36.5 (6.7) | 41.3 (5.2) | <0.001 | −4.8 (1.9) | 0.549 a |
6 or more than 6 months | 41 | 36.7 (5.8) | 42.7 (6.1) | <0.001 | −6 (3.7) |
MMO | ||||||
---|---|---|---|---|---|---|
Number | T1 (Mean (SD)) | T2 (Mean (SD)) | p Value * | Difference of MMO (Mean (SD)) | p Value † | |
Appliance treatment | ||||||
No splint | 34 | 36.1 (5.8) | 43.2 (6.3) | <0.001 | −7.1 (4.7) | 0.492 a |
Splint tx | 45 | 36.9 (7.2) | 42.6 (6.2) | <0.001 | −5.7 (5.1) | |
Dx | ||||||
Group 1 | 22 | 34.2 (5.5) | 42.7 (6.2) | <0.001 | −8.5 (5.5) | 0.598 b |
Group 2 | 45 | 37.1 (4.7) | 43.1 (4.1) | <0.001 | −6 (4.9) | |
Group 3 | 12 | 37.2 (5.2) | 42.9 (5.1) | <0.001 | −5.7 (5.2) | |
Muscle relaxant and anti-inflamatuar drug | ||||||
No | 15 | 36.3 (5.1) | 42.6 (5.1) | <0.001 | −6.3 (4.4) | 0.398 a |
Yes | 64 | 37.8 (5.1) | 42.9 (5.9) | <0.001 | −5.1 (4.1) | |
Physical therapy | ||||||
No | 18 | 34.7 (5.5) | 42.3 (6.1) | <0.001 | −7.6 (4.6) | 0.544 a |
Yes | 61 | 37.0 (4.6) | 42.9 (5.2) | <0.001 | −5.9 (4.3) | |
Locking time | ||||||
Less than 6 months | 35 | 36.5 (6.7) | 42.7 (5.2) | <0.001 | −6.2 (3.9) | 0.889 a |
6 or more than 6 months | 41 | 36.7 (5.8) | 43.1 (6.1) | <0.001 | −6.4 (4.3) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Demir, M.G. The Effect of Arthrocentesis Treatment for Maximum Mouth Opening and Pain in Temporomandibular Joint Diseases and the Effect of Splint, Drug, and Physical Therapy on This Treatment. Medicina 2023, 59, 1767. https://doi.org/10.3390/medicina59101767
Demir MG. The Effect of Arthrocentesis Treatment for Maximum Mouth Opening and Pain in Temporomandibular Joint Diseases and the Effect of Splint, Drug, and Physical Therapy on This Treatment. Medicina. 2023; 59(10):1767. https://doi.org/10.3390/medicina59101767
Chicago/Turabian StyleDemir, Mehmet Gökhan. 2023. "The Effect of Arthrocentesis Treatment for Maximum Mouth Opening and Pain in Temporomandibular Joint Diseases and the Effect of Splint, Drug, and Physical Therapy on This Treatment" Medicina 59, no. 10: 1767. https://doi.org/10.3390/medicina59101767